@inproceedings{jacques94a, author = {S. L. Jacques and L. Buckley and S. Prahl and K. Gregory}, title = {Quantifying Psoralen in Tissues by Fluorescence: Dosimetry for Psoralen Administration Followed by Ultraviolet {A} Irradiation ({Puva}) to Block Restenosis}, booktitle = {SPIE Proceedings of Diagnostic and Therapeutic Cardiovascular Interventions IV}, year = {1994}, volume = {2130}, pages = {82--88}, editor = {G. S. Abela}, abstract = {PUVA therapy may prove effective in preventing restenosis of vessels following balloon angioplasty to open vessels narrowed by atherosclerosis. The technique relies on the ability of PUVA (psoralen administration followed by ultraviolet A irradiation) to cause crosslinks and monoadducts that prevent cellular proliferation without causing cell death. Such PUVA treatment has been successful in controlling cutaneous cell proliferation of psoriasis. The efficacy of PUVA treatment depends on the drug concentration and the light dose. The amount of light delivered is easily modified to adapt to variations in the drug concentration if the drug levels in the vessel wall are known. This paper demonstrates the feasibility of assaying psoralen levels in tissues and in serum samples using psoralen fluorescence as an indictor.}, }